Valuation: EUROAPI

Market Cap 13Cr 15Cr 12Cr 11Cr 21Cr 1.42TCr 22Cr 144.3Cr 56Cr 700.21Cr 56Cr 55Cr 2.41TCr P/E 2026 *
-1.72x
P/E 2027 * -3.25x
Enterprise Value 8.91Cr 10Cr 8.19Cr 7.63Cr 14Cr 970.73Cr 15Cr 98Cr 38Cr 477.17Cr 38Cr 37Cr 1.64TCr EV / Sales 2026 *
0.12x
EV / Sales 2027 * 0.16x
Free-Float
65.03%
Yield 2026 *
-
Yield 2027 * -
1 day+3.31%
1 week+4.41%
Current month+3.00%
1 month+7.18%
3 months+8.62%
6 months-37.55%
Current year-39.47%
1 week 1.28
Extreme 1.284
1.39
1 month 1.22
Extreme 1.22
1.39
Current year 1.22
Extreme 1.22
2.28
1 year 1.22
Extreme 1.22
3.44
3 years 1.22
Extreme 1.22
12.97
5 years 1.22
Extreme 1.22
19.02
10 years 1.22
Extreme 1.22
19.02
Manager TitleAgeSince
Chief Executive Officer - 09/12/2024
Director of Finance/CFO - 17/10/2024
Compliance Officer - 27/11/2023
Director TitleAgeSince
Director/Board Member - 06/05/2022
Director/Board Member 54 11/01/2023
Director/Board Member 48 22/02/2023
Date Insider Type Main position Quantity % Market Cap.
01/23/01Buy

Chief Financial Officer

635 0.0007%
01/23/01Buy

Chief Financial Officer

620 0.0007%
01/23/01Buy

Chief Financial Officer

610 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+3.31%+4.41%-57.36%-86.67% 15Cr
+1.86%+0.48%+55.50%+163.08% 1,08200Cr
+3.57%+3.29%+68.60%+61.03% 63TCr
+3.99%+3.05%+37.93%+93.37% 46TCr
+3.86%+1.64%+31.35%+24.29% 34TCr
-0.56%+0.96%+39.86%+36.64% 30TCr
-0.08%+1.30%+30.37%+44.02% 29TCr
-1.54%+2.81%-27.56%-39.45% 22TCr
+3.55%+4.41%+25.45%+66.28% 20TCr
+4.21%+2.65%+17.47%+71.11% 16TCr
Average +2.22%+4.56%+22.16%+43.37% 36.93TCr
Weighted average by Cap. +2.25%+5.53%+41.78%+83.00%

Financials

2026 *2027 *
Net sales 76Cr 87Cr 70Cr 65Cr 123.56Cr 8.28TCr 125.43Cr 839Cr 326.16Cr 4.07TCr 326.52Cr 319.51Cr 14TCr 78Cr 89Cr 72Cr 67Cr 126.99Cr 8.51TCr 128.91Cr 862.3Cr 335.21Cr 4.18TCr 335.59Cr 328.38Cr 14TCr
Net income -7.57Cr -8.66Cr -6.96Cr -6.48Cr -12Cr -824.51Cr -12Cr -84Cr -32Cr -405.29Cr -33Cr -32Cr -1.4TCr -4.03Cr -4.6Cr -3.7Cr -3.45Cr -6.54Cr -438.42Cr -6.64Cr -44Cr -17Cr -215.51Cr -17Cr -17Cr -742.62Cr
Net Debt -4.17Cr -4.77Cr -3.83Cr -3.57Cr -6.77Cr -453.76Cr -6.87Cr -46Cr -18Cr -223.05Cr -18Cr -18Cr -768.6Cr -50.63L -57.92L -46.53L -43.37L -82.27L -55Cr -83.51L -5.59Cr -2.17Cr -27Cr -2.17Cr -2.13Cr -93Cr
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
03/26/03 €1.374 +3.31% 79,234
02/26/02 €1.330 -0.60% 1,14,849
01/26/01 €1.338 +0.30% 69,289
30/26/30 €1.334 +1.83% 74,318
29/26/29 €1.310 -0.46% 1,71,490
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
1.374EUR
Average target price
1.475EUR
Spread / Average Target
+7.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EAPI Stock